LY 3000328 (Cathepsin S inhibitor) 是 Cathepsin S 的选择性抑制剂,抑制人和小鼠Cat S 的IC50分别为7.7,1.67 nM。LY 3000328 (Cathepsin S inhibitor)可以通过抑制 Cathepsin S 介导的细胞外基质蛋白、弹性蛋白和胶原蛋白的降解来减缓或阻止腹主动脉瘤 (AAA) 扩张和 或降低 AAA 破裂的风险。
Hydrocortisone buteprate (Hydrocortisone probutate) is a medium potent, non-halogenated double-ester of hydrocortisone with a favorable benefit risk ratio for the treatment of inflammatory skin disorders.
Lidoflazine is a high-affinity blocker of the HERG K+ channel and is an antianginal calcium channel blocker. It carries an obvious risk of QT interval prolongation and ventricular arrhythmia.
Odiparcil is an orally active beta-d-thioxyloside analog. Odiparcil is an indirect thrombin inhibitor that exerts its anticoagulant effect through activation of antithrombin II (heparin cofactor II). It also has an antithrombotic activity associated with a reduced risk of adverse bleeding events.